The new article highlights the aspects related to the key design considerations for sensors, actuators, safety features and user interfaces.
Table of content
The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products, has published a guidance document dedicated to technical considerations for medical devices with physiologic closed-loop control technology.
The document provides an overview of the applicable regulatory requirements, as well as additional clarifications and recommendations to be taken into consideration by medical device manufacturers and other parties involved in order to ensure compliance thereto.
At the same time, provisions of the guidance are non-binding in their legal nature, nor are they intended to introduce new rules or impose new obligations.
Moreover, the authority explicitly states that an alternative approach could be applied, provided such an approach is in line with the existing regulatory framework and has been agreed with the authority in advance.
The scope of the guidance covers, inter alia, the aspects related to considerations for PCLC device design, providing additional details about sensors, and actuators, as well as system integration and safety features.
The document also addresses briefly the matters associated with the user interface.
Sensors in PCLC Devices
Physiologic-measuring sensors are integral to the operation of PCLC devices.
They supply crucial feedback variables that have correlations with physiologic variables under control. One of the most significant challenges faced is the inability to directly sense the physiologic variable.
A typical example is found in neonatal care.
For neonates requiring oxygen, directly measuring arterial oxygen saturation (SaO2) isn’t always feasible. Manufacturers resort to an alternative: measuring functional peripheral oxygen saturation (SpO2) through pulse oximeters.
The criticality lies in the accuracy of SpO2 as an indicator of SaO2.
The relationship between the feedback and the physiologic variable influences the safety and performance of the PCLC device.
It is vitally important to establish the performance of this feedback and identify any limitations.
Considering the example of an automated anaesthesia delivery system, the impact of drugs, motion artefacts, and surgical disturbances on the sensed depth of hypnosis is crucial.
Manufacturers are advised to consider carefully the risks related to sensor performance. Key considerations include:
- Measurement accuracy and precision.
- Sensor uncertainty across its measurement range.
- Response time and delay considerations.
- Potential variations in performance due to factors such as measurement range, patient-specific conditions, environmental factors, and calibration drift.
- Update rate and electronic data interface specifications.
- Sources of signal artefacts and their impact on sensor performance.
Manufacturers must also consider monitoring sensor performance for faults or calibration drifts, possibly reverting to backup systems or modes as necessary.
Actuators in PCLC Devices
As further explained by the FDA, actuators play a pivotal role in translating the output from the control algorithm into actual therapeutic interventions for the patient.
The failure of these components has the potential to cause negative consequences. According to the guidance, recommendations for designing or selecting actuators include:
- Ensuring high levels of accuracy and precision.
- Minimizing response time.
- I am recognizing physical limitations and ensuring compatibility with control algorithms.
- Addressing electronic data interface specifications and potential communication delays.
Some PCLC devices may need constant monitoring to identify actuator-related issues, enabling swift transitions to backup or fallback modes.
System Integration
The integration of various components, such as sensors, actuators, and control algorithms, is vitally important for the proper functioning of a PCLC device.
Manufacturers should take into account all potential challenges related to component interfacing and system integration.
The authority additionally emphasizes the importance of ensuring the quality and timeliness of data exchange between components.
Manufacturers are expected to follow FDA recommendations and other relevant standards to ensure seamless integration and interoperability.
System Safety Features
As it was mentioned before, safety remains vitally important when it comes to the use of PCLC technology in medical devices.
Beyond the primary control loop, multiple design elements enhance system safety. Key features include:
- Fallback modes for detection of unsafe conditions and ensuring patient safety.
- Transparent criteria for initiating and ending automated therapy.
- Constraining the delivery of energy or therapeutic articles.
- Efficient data logging to maintain system variable logs, clinician interventions, and other essential data.
- Implementing robust alarm systems in line with international standards to alert users of potentially hazardous situations.
Conclusion
In summary, the development and deployment of PCLC devices require rigorous attention to detail, integrating sensors and actuators, ensuring system safety, and creating user-friendly interfaces.
Adherence to these principles and guidelines ensures that these devices not only perform their intended functions but also comply with the highest standards of patient safety.
How Can RegDesk Help?
RegDesk is a holistic Regulatory Information Management System that provides medical device and pharma companies with regulatory intelligence for over 120 markets worldwide. It can help you prepare and publish global applications, manage standards, run change assessments, and obtain real-time alerts on regulatory changes through a centralized platform. Our clients also have access to our network of over 4000 compliance experts worldwide to obtain verification on critical questions. Global expansion has never been this simple.
